MapLight Therapeutics, Inc. filed a Form D with the Securities and Exchange Commission on 2025-07-28.
MapLight Therapeutics, Inc. filed a Form D notice of an exempt securities offering with the SEC on July 28, 2025. The filing reports $188.19M sold. Its industry group is Biotechnology. It names Christopher Kroeger (Executive Officer, Director), George Pavlov (Director), Timothy Garnett (Director) (SEC Form D, July 28, 2025).
Is this your company?
Sell to companies like MapLight Therapeutics, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2025-07-28 · the record
Pitching, partnering or investing alongside them? See who really runs and owns MapLight Therapeutics, Inc.
Free to see. No signup.
More on the people and the money behind MapLight Therapeutics, Inc., from the filings we hold.
Biotechnology raises by companies based in California, filed in July 2025, largest first.
Get an email when MapLight Therapeutics, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when MapLight Therapeutics, Inc. raises, hires or launches. No email unless you switch it on.
Watch MapLight Therapeutics, Inc. →Get the full cited report on MapLight Therapeutics, Inc.
What the filing shows about MapLight Therapeutics, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on MapLight Therapeutics, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The filing gives MapLight Therapeutics, Inc.'s address as 800 Chesapeake Drive, Redwood City, CA 94063.
Saved here on this device in the meantime, so nothing is lost either way.
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
Order the Full Report on MapLight Therapeutics, Inc. See pricing
MapLight Therapeutics, Inc. is a registered filer with the SEC (CIK 1770069) and has filed since 2022-11-10. 4 filings are on record, the latest on 2025-07-28.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
MapLight Therapeutics, Inc.'s Form D of 2025-07-28 names Christopher Kroeger, George Pavlov, Timothy Garnett and 10 more as its officers, directors or promoters.
Its new offerings report $250.19M sold across 3 offerings, as its own filings state.
A hollow marker is an amendment (Form D/A); a solid one is an original Form D. The larger marker is the filing this page is about.
Trailing twelve months. 769 filings in Biotechnology, totalled by week.
Christopher Kroeger is named as Executive Officer and Director on the Form D that MapLight Therapeutics, Inc. filed with the SEC on 28 July 2025, one of 13 people that filing names.
George Pavlov is named as Director on the Form D that MapLight Therapeutics, Inc. filed with the SEC on 28 July 2025, one of 13 people that filing names.
Timothy Garnett is named as Director on the Form D that MapLight Therapeutics, Inc. filed with the SEC on 28 July 2025, one of 13 people that filing names.
James Lillie is named as Executive Officer on the Form D that MapLight Therapeutics, Inc. filed with the SEC on 28 July 2025, one of 13 people that filing names.
Peter Bisgaard is named as Director on the Form D that MapLight Therapeutics, Inc. filed with the SEC on 28 July 2025, one of 13 people that filing names.
Jonathan Gillis is named as Executive Officer on the Form D that MapLight Therapeutics, Inc. filed with the SEC on 28 July 2025, one of 13 people that filing names.
Vishwas Setia is named as Executive Officer on the Form D that MapLight Therapeutics, Inc. filed with the SEC on 28 July 2025, one of 13 people that filing names.
Jim Trenkle is named as Director on the Form D that MapLight Therapeutics, Inc. filed with the SEC on 28 July 2025, one of 13 people that filing names.
Maria Walker is named as Director on the Form D that MapLight Therapeutics, Inc. filed with the SEC on 28 July 2025, one of 13 people that filing names.
Kristopher Hanson is named as Executive Officer on the Form D that MapLight Therapeutics, Inc. filed with the SEC on 28 July 2025, one of 13 people that filing names.
Nanna Luneborg is named as Director on the Form D that MapLight Therapeutics, Inc. filed with the SEC on 28 July 2025, one of 13 people that filing names.
Erin Foff is named as Executive Officer on the Form D that MapLight Therapeutics, Inc. filed with the SEC on 28 July 2025, one of 13 people that filing names.
Anatol Kreitzer is named as Executive Officer on the Form D that MapLight Therapeutics, Inc. filed with the SEC on 28 July 2025, one of 13 people that filing names.
13 people named on the filing — 7 holding an executive role and 6 as directors only.
Named as of the 2025-07-28 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
Of the 13 names on this filing, 12 are drawn here to keep the picture readable. The People tab lists them all.
No investor is drawn from a Form D — the form states how many invested and never who.
What the filing shows about MapLight Therapeutics, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on MapLight Therapeutics, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on MapLight Therapeutics, Inc. covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist MapLight Therapeutics, Inc.You get an alert in MentionFox the next time this company shows up.
If you're behind MapLight Therapeutics, Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov.
Each opens in a new tab, filled in for MapLight Therapeutics, Inc.. With no account yet, you sign up free and land on the result.
On these lists: Biotech raises in San Francisco Bay Area
Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.
https://mentionfox.com/funding/maplight-therapeutics-inc-form-d-25000001